Immune-Therapy in Cutaneous Melanoma – Efficacy Immune Markers

Neagu, Monica; Constantin, Carolina

doi:10.5772/23493

Cited by 1 publication

(1 citation statement)

References 90 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Unveiling chronic inflammation patterns related to tumorigenesis can further direct/redirect the therapy choice and furnish identification of new target molecules (166). There are still questions to be answered, such as the link between sex steroid hormones and inflammation and the involvement of inflammation pattern in immunosuppressive mechanisms, but future research would further elucidate the inflammatory complex networks that should be driven towards antitumorigenic processes.…”

Section: Resultsmentioning

confidence: 99%

Inflammation: A key process in skin tumorigenesis (Review)

et al. 2018

Self Cite

View full text Add to dashboard Cite

The extremely delicate shift from an inflammatory process to tumorigenesis is a field of major scientific interest. While the inflammation induced by environmental agents has well known underlying mechanisms, less is known concerning the oncogenic changes that follow an inflammatory chronic status in the tissue microenvironment that can lead to pro-tumorigenic processes. Regardless of the origin of the environmental factors, the maintenance of an inflammatory microenvironment is a clear condition that favors tumorigenesis. Inflammation sustains the proliferation and survival of malignant transformed cells, can promote angiogenesis and metastatic processes, can negatively regulate the antitumoral adaptive and innate immune responses and may alter the efficacy of therapeutic agents. There is an abundance of studies focusing on molecular pathways that trigger inflammation-mediated tumorigenesis, and these data have revealed a series of biomarkers that can improve the diagnosis and prognosis in oncology. In skin there is a clear connection between tissue destruction, inflammation and tumor onset. Inflammation is a self-limiting process in normal physiological conditions, while tumor is a constitutive process activating new pro-tumor mechanisms. Among skin cancers, the most commonly diagnosed skin cancers, squamous cell carcinoma and basal cell carcinoma (BCC) have important inflammatory components. The most aggressive skin cancer, melanoma, is extensively research in regards to the new context of novel developed immune-therapies. In skin cancers, inflammatory markers can find their place in the biomarker set for improvement of diagnosis and prognosis.

show abstract

Section: Resultsmentioning

confidence: 99%